The effect of bivalent HPV vaccination against invasive cervical cancer and cervical intraepithelial neoplasia grade 3 (CIN3+) in the Netherlands: a population-based linkage study
Authors
Johannes Berkhof (ORCID: https://orcid.org/0000-0003-2094-2380)
Hester E. de Melker (ORCID: https://orcid.org/0000-0001-9100-1639)
Folkert J. van Kemenade (ORCID: https://orcid.org/0000-0002-4225-4354)
The effect of bivalent HPV vaccination against invasive cervical cancer and cervical intraepithelial neoplasia grade 3 (CIN3+) in the Netherlands: a population-based linkage study
Johannes Berkhof, Hester E. de Melker, Folkert J. van Kemenade, Marit Middeldorp et al.
Citations
6 citations
Journal
The Lancet Regional Health - Europe
Topics
Cervical Cancer and HPV Research
Field-Weighted Citation Impact (FWCI)
8.13
article
The effect of bivalent HPV vaccination against invasive cervical cancer and cervical intraepithelial neoplasia grade 3 (CIN3+) in the Netherlands: a population-based linkage study
Johannes Berkhof, Hester E. de Melker, Folkert J. van Kemenade, Marit Middeldorp, Janneke W. Duijster, Albert G. Siebers, Jesca G.M. Brouwer, Mirjam J. Knol
article en
6 citations
Abstract
No abstract available for this paper.
Publication Tag
The Lancet Regional Health - EuropeVol. 54
Institutions
Erasmus MC (NL), National Institute for Public Health and the Environment (NL), Amsterdam University Medical Centers (NL), Nationwide Mutual Insurance Company (United States) (US), Amsterdam UMC Location Vrije Universiteit Amsterdam (NL)